CLINICAL_TRIALS
research
· 2025-07-16
Clinical Trial Update: Ketamine + Magnesium for Chronic Cluster Headache (KETALGIA) [Phase 4]
Summary
A Phase 4 clinical trial (KETALGIA) is investigating ketamine plus magnesium for refractory chronic cluster headache and is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University Hospital, Clermont-Ferrand | Conditions: Refractory Chronic Cluster Headache | Phase 4 | Status: RECRUITING